pentamidine has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies
Pentamidine: Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects.
pentamidine : A diether consisting of pentane-1,5-diol in which both hydroxyl hydrogens have been replaced by 4-amidinophenyl groups. A trypanocidal drug that is used for treatment of cutaneous leishmaniasis and Chagas disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Her, S | 1 |
| Cui, L | 1 |
| Bristow, RG | 1 |
| Allen, C | 1 |
1 other study available for pentamidine and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Dual Action Enhancement of Gold Nanoparticle Radiosensitization by Pentamidine in Triple Negative Breast Cancer.
Topics: Biological Transport; Cell Cycle; Cell Line, Tumor; DNA Breaks, Double-Stranded; Drug Synergism; Gol | 2016 |